Renaissance Technologies’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190K | Buy |
+10,988
| New | +$190K | ﹤0.01% | 3183 |
|
|
2025
Q1 | – | Sell |
-271,913
| Closed | -$8.68M | – | 3440 |
|
|
2024
Q4 | $8.68M | Sell |
271,913
-100,418
| -27% | -$3.2M | 0.01% | 1108 |
|
|
2024
Q3 | $10.7M | Buy |
+372,331
| New | +$10.7M | 0.02% | 1009 |
|
|
2023
Q3 | – | Sell |
-138,513
| Closed | -$12.6M | – | 3632 |
|
|
2023
Q2 | $12.6M | Buy |
+138,513
| New | +$12.6M | 0.02% | 906 |
|
|
2023
Q1 | – | Sell |
-187,413
| Closed | -$9.69M | – | 3955 |
|
|
2022
Q4 | $9.69M | Sell |
187,413
-157,700
| -46% | -$8.15M | 0.01% | 1099 |
|
|
2022
Q3 | $23.6M | Buy |
+345,113
| New | +$23.6M | 0.03% | 596 |
|
|
2021
Q3 | – | Sell |
-20,211
| Closed | -$1.28M | – | 3448 |
|
|
2021
Q2 | $1.28M | Sell |
20,211
-353,302
| -95% | -$22.3M | ﹤0.01% | 2541 |
|
|
2021
Q1 | $16M | Buy |
373,513
+157,200
| +73% | +$6.75M | 0.02% | 909 |
|
|
2020
Q4 | $12.4M | Buy |
+216,313
| New | +$12.4M | 0.01% | 1023 |
|
|
2020
Q1 | – | Sell |
-19,513
| Closed | -$597K | – | 3425 |
|
|
2019
Q4 | $597K | Buy |
+19,513
| New | +$597K | ﹤0.01% | 2830 |
|
|
2019
Q2 | – | Sell |
-26,200
| Closed | -$511K | – | 3528 |
|
|
2019
Q1 | $511K | Buy |
+26,200
| New | +$511K | ﹤0.01% | 2917 |
|